1168630

Labcorp Drug Development — FEI 2242945

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 25, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Princeton, NJ (United States)

Additional Details

Sponsor, Contract Research Organization